TECH Stock Analysis: Buy, Sell, or Hold?
TECH - Bio-Techne Corp.
$56.26
0.65 (1.17%)
▲
5d:
+0.16%
30d:
+18.77%
90d:
+8.19%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When TECH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TECH is fairly valued with market pricing in 0.8% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: TECH is fairly valued with market pricing in 0.8% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$67.09
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$41.65
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TECH is currently trading at $56.26, which is considered extended relative to its 30-day fair value range of $47.46 to $55.26. The stock's valuation (Forward PE: 27.4) is in line with its historical norms (26.7). At these levels, the market is pricing in 0.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TECH is in a strong downtrend. The price is approaching resistance at $55.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TECH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TECH is in a strong downtrend. The price is approaching resistance at $55.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TECH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$47.46 -
$55.26
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($61.31)
- NEUTRAL: Market pricing in 0.8% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$47.46 -
$55.26
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$47.22
Resistance Level
$55.16
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.39
Wall Street Target
$61.31
(+9.0%)
Revenue Growth (YoY)
-1.5%
Earnings Growth (YoY)
128.6%
Profit Margin
9.0%
Valuation Premium vs History
+0.8% premium
PE vs Historical
27.4 vs 26.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.8%
(market-implied from PE analysis)
1-Year Target
$56.71
(+1%)
2-Year Target
$57.16
(+2%)
3-Year Target
$57.62
(+2%)
3-Yr Target (if PE normalizes)
(PE: 27→27)
PE COMPRESSION
$56.16
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.4, Growth: 7.0%)
$68.94
(+23%)
Base:
(SPY PE: 21.8, Growth: 7.0%)
$54.81
(-3%)
Bear:
(PE: 18.5, Growth: 7.0%)
$46.59
(-17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Forward PE: 28.41 | Forward EPS (Implied): $1.96
Bull Case
$67.15
(+21%)
Analyst growth 15.0%, PE expands to 29.8
Base Case
$55.61
(0%)
Market implied 0.0%, PE stable at 28.4
Bear Case
$42.54
(-24%)
Severe decline -15.0%, PE contracts to 25.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TECH showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
April McClain Delaney
SELL
2026-03-26
April McClain Delaney
SELL
2026-02-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
